Exosens (EPA:EXENS)
France · Delayed Price · Currency is EUR 60.95
-1.25 (-2.01%)
Aug 21, 2026, 5:35 PM CET
Exosens Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 501.78 | 468.19 | 383.44 | 291.82 | 200.75 | 166.17 | |
Revenue Growth | 20.61% | 22.10% | 31.40% | 45.36% | 20.81% | 10.88% |
Cost of Revenue | 200.08 | 186.99 | 157.51 | 126.82 | 84.46 | 64.57 |
Gross Profit | 301.7 | 281.19 | 225.93 | 165 | 116.29 | 101.6 |
Selling, General & Admin | 148.76 | 139.13 | 110.89 | 84.51 | 64.63 | 57.74 |
Other Operating Expenses | -1.97 | -1.92 | -0.2 | -2.55 | 1.03 | 14.38 |
Operating Expenses | 214.41 | 177.09 | 145.35 | 112.36 | 86.2 | 72.12 |
Operating Income | 87.29 | 104.1 | 80.58 | 52.64 | 30.09 | 29.48 |
Interest Expense | -11.78 | -12.1 | -35.53 | -26.91 | -15.15 | -37.6 |
Currency Exchange Gain (Loss) | 0.27 | -2.66 | 2.15 | -2.68 | 1.57 | 4.38 |
Other Non Operating Income (Expenses) | -0.04 | 0.92 | 2.32 | 1.54 | 2.93 | -2.66 |
EBT Excluding Unusual Items | 75.74 | 90.27 | 49.52 | 24.6 | 19.43 | -6.4 |
Merger & Restructuring Charges | -3.05 | -2.09 | -3.8 | -4.36 | -2.32 | - |
Impairment of Goodwill | - | - | - | - | - | -143.87 |
Pretax Income | 72.69 | 88.18 | 45.72 | 20.24 | 17.11 | -150.26 |
Income Tax Expense | 16.77 | 17.99 | 11.64 | 1.83 | 5.89 | -1.3 |
Earnings From Continuing Operations | 55.92 | 70.19 | 34.08 | 18.41 | 11.21 | -148.97 |
Earnings From Discontinued Operations | -25.77 | -27.48 | -3.4 | - | - | - |
Net Income | 30.15 | 42.72 | 30.68 | 18.41 | 11.21 | -148.97 |
Preferred Dividends & Other Adjustments | - | - | 5.15 | 11.05 | 10.41 | - |
Net Income to Common | 30.15 | 42.72 | 25.53 | 7.36 | 0.8 | -148.97 |
Net Income Growth | -45.90% | 67.31% | 247.12% | 815.94% | - | - |
Shares Outstanding (Basic) | 51 | 51 | 42 | 30 | 76 | 76 |
Shares Outstanding (Diluted) | 51 | 51 | 42 | 30 | 76 | 76 |
Shares Change | -0.55% | 21.65% | 37.23% | -60.00% | - | - |
EPS (Basic) | 0.60 | 0.84 | 0.61 | 0.24 | 0.01 | -1.96 |
EPS (Diluted) | 0.59 | 0.84 | 0.61 | 0.24 | 0.01 | -1.96 |
EPS Growth | -45.63% | 37.70% | 154.17% | 2300.00% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 58.04 | 49.93 | 54.34 | 19.53 | 25.69 | 23.07 |
Free Cash Flow Per Share | 1.15 | 0.98 | 1.30 | 0.64 | 0.34 | 0.30 |
Dividend Per Share | 0.300 | 0.300 | 0.100 | - | - | - |
Dividend Growth | 200.00% | 200.00% | - | - | - | - |
Gross Margin | 60.13% | 60.06% | 58.92% | 56.54% | 57.93% | 61.14% |
Operating Margin | 17.39% | 22.23% | 21.02% | 18.04% | 14.99% | 17.74% |
Profit Margin | 6.01% | 9.12% | 6.66% | 2.52% | 0.40% | -89.65% |
Free Cash Flow Margin | 11.57% | 10.66% | 14.17% | 6.69% | 12.80% | 13.88% |
EBITDA | 104.89 | 128.97 | 96.42 | 71.94 | 43.56 | 34.99 |
EBITDA Margin | 20.90% | 27.55% | 25.14% | 24.65% | 21.70% | 21.05% |
D&A For EBITDA | 17.6 | 24.87 | 15.84 | 19.29 | 13.47 | 5.5 |
EBIT | 87.29 | 104.1 | 80.58 | 52.64 | 30.09 | 29.48 |
EBIT Margin | 17.39% | 22.23% | 21.02% | 18.04% | 14.99% | 17.74% |
Effective Tax Rate | 23.07% | 20.40% | 25.46% | 9.06% | 34.45% | - |
Advertising Expenses | - | 1.86 | 2.02 | 1.65 | 1.47 | 0.76 |